DOI
https://doi.org/10.18849/ve.v1i1.9Abstract
Oral phenobarbital and imepitoin in particular, followed by potassium bromide and levetiracetam are likely to be effective for the treatment of canine idiopathic epilepsy. There is strong evidence supporting the use of oral phenobarbital and imepitoin as ‘first line’ medications. However, there remains a lack of evidence for targeted treatment for the various individual epileptic phenotypes and quite limited evidence on direct comparisons of the efficacy between various anti-epileptic drugs.
References
Bhatti, S. F. et al. (2015) International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe. BMC Veterinary Research, 11:176 http://dx.doi.org/10.1186/s12917-015-0464-z
Boothe, D.M., Dewey, C. and Carpenter, D.M. (2012) Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs. Journal of the American Veterinary Medical Association, 240 (9), pp. 1073-1083 http://dx.doi.org/10.2460/javma.240.9.1073
Charalambous, M., Brodbelt, D., & Volk, H. A. (2014). Treatment in canine epilepsy–a systematic review. BMC Veterinary Research, 10:257 http://dx.doi.org/10.1186/s12917-014-0257-9
Chung, J.Y., et al. (2012) Zonisamide monotherapy for idiopathic epilepsy in dogs. New Zealand Veterinary Journal, 60 (6), pp. 357-359 http://dx.doi.org/10.1080/00480169.2012.680855
Cunningham, J.G., Haidukewych, D., Jensen, H.A. (1983) Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs. Journal of the American Veterinary Medical Association, 182 (10), pp. 1091-1094
De Risio, L.,et al. (2015) International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs. BMC Veterinary Research, 11:148. http://dx.doi.org/10.1186/s12917-015-0462-1
Dewey, C.W., et al. (2009) Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy. Journal of the American Veterinary Medical Association, 235 (12), pp. 1442-1449 http://dx.doi.org/10.2460/javma.235.12.1442
Dewey C.W. et al. (2004) Zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of the American Animal Hospital Association, 40 (4), pp. 285-291 http://dx.doi.org/10.5326/0400285
European Medicines Agency (2012) CVMP assessment report for Pexion (EMEA/V/C/002543/0000). London: EMEA
Fredsø, N. et al. (2014) Risk factors for survival in a university hospital population of dogs with epilepsy. Journal of Veterinary Internal Medicine 28 (6), pp. 1782-1788 http://dx.doi.org/10.1111/jvim.12443
Gaskill, C.L. and Kimber, W.J. (2010) Comparison of phenobarbital and potassium bromide monotherapies in the treatment of canine epilepsy. Journal of Veterinary Internal Medicine, 24 (3), pp. 696
Govendir, M., Perkins, M. and Malik, R. (2005) Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Australian Veterinary Journal, 83 (10) pp. 602-608 http://dx.doi.org/10.1111/j.1751-0813.2005.tb13269.x
Heynold, Y.et al. (1997) Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 labrador retrievers: a long-term study. The Journal of Small Animal Practice, 38 (1), pp. 7-14 http://dx.doi.org/10.1111/j.1748-5827.1997.tb02977.x
Jambroszyk, M., Tipold, A. and Potschka, H. (2011) Add-on treatment with verapamil in pharmacoresistant canine epilepsy. Epilepsia, 52 (2), pp. 284-291 http://dx.doi.org/10.1111/j.1528-1167.2010.02886.x
Kis, I. et al. (2012) The concentration of phenobarbital in dogs with idiopathic epilepsy in Croatia. In: Peti Hrvatski Veterinarski Kongres s Meunarodnim Sudjelovanjem (5th Croatian Veterinary Congress), Tuheljske Toplice, Croatia, 10-13 October, pp. 397-403.
Kiviranta, A.-M. et al. (2013) Topiramate as an add-on antiepileptic drug in treating refractory canine idiopathic epilepsy. Journal of Small Animal Practice, 54 (10), pp. 512-520. http://dx.doi.org/10.1111/jsap.12130
Law, T. H. et al. (2015) A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy. British Journal of Nutrition, 114 (09), pp. 1438-1447 http://dx.doi.org/10.1017/S000711451500313X
Loscher, W. et al. (2004) Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia, 45 (10), pp. 1228-1239 http://dx.doi.org/10.1111/j.0013-9580.2004.21204.x
Matthews, H. et al. (2012) Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial. Veterinary Journal, 191 (3), pp. 396-398 http://dx.doi.org/10.1016/j.tvjl.2011.04.018
Morton, D.J. and Honhold, N. (1988) Effectiveness of a therapeutic drug monitoring service as an aid to the control of canine seizures. Veterinary Record, 122(15), pp. 346-349 http://dx.doi.org/10.1136/vr.122.15.346
Munana, K.R. et al (2012) Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial. Journal of Veterinary Internal Medicine 26 (2), pp. 341-348 http://dx.doi.org/10.1111/j.1939-1676.2011.00866.x
Muñana, K. R. et al (2002) Use of vagal nerve stimulation as a treatment for refractory epilepsy in dogs. Journal of the American Veterinary Medical Association, 221 (7), pp. 977-983 http://dx.doi.org/10.2460/javma.2002.221.977
Musteata, M., Hagiu, N. and Ghe, S. (2007) Therapeutic efficiency of the gabapentin-phenobarbital medication in refractory idiopathic epilepsy in dog. Medicina Veterinara, 51, pp. 352-357
Nafe, L.A. and Kay, W. J. (1981) Sodium valproate: a preliminary clinical trial in epileptic dogs. Journal of the American Animal Hospital Association, 17 (1), pp. 131-133
O'Brien, D.P.et al. (1997) Nimodipine for treatment of idiopathic epilepsy in dogs. Journal of the American Veterinary Medical Association, 210 (9), pp. 1298-1301
Packer, R.M.A. et al (2015a) Assessment into the usage of levetiracetam usage in canine epilepsy. BMC Veterinary Research, 11 (25) http://dx.doi.org/10.1186/s12917-015-0340-x
Packer, R. M. A. et al. (2015b) Responses to successive anti-epileptic drugs in canine idiopathic epilepsy. Veterinary Record, 176 (8), pp. 203-205. http://dx.doi.org/10.1136/vr.102934
Packer, R. M. A., Shihab, N. K., Torres, B. B. J., & Volk, H. A. (2014) Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsy. PLoS ONE, 9(8) http://dx.doi.org/10.1371/journal.pone.0106026
Patterson, E.E. et al. (2005) Results of a ketogenic food trial for dogs with idiopathic epilepsy. Journal of Veterinary Internal Medicine, 19 (3) p. 421 http://dx.doi.org/10.1111/j.1939-1676.2005.tb00640.x
Pearce, L. K. (1990) Potassium bromide as an adjunct to Phenobarbital for the management of uncontrolled seizures in dogs. Progress in Veterinary Neurology, 1, pp. 95-101
Platt, S. R. et al. (2006) Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Veterinary Record, 159 (26), pp. 881-884 http://dx.doi.org/0.1136/vr.159.26.881Podell, M. and Fenner, W.R. (1993) Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine 7 (5), pp. 318-327 http://dx.doi.org/10.1111/j.1939-1676.1993.tb01025.x
Rieck, S., Rundfeldt, C. and Tipold, A. (2006) Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot study. Veterinary Journal, 172 (1), pp. 86-95 http://dx.doi.org/10.1016/j.tvjl.2005.04.003
Ruehlmann, D., Podell, M., March, P. (2001) Treatment of partial seizures and seizure-like activity with felbamate in six dogs. Journal of Small Animal Practice, 42 (8), pp. 403-408 http://dx.doi.org/10.1111/j.1748-5827.2001.tb02490.x
Rundfeldt, C., Tipold, A. and Löscher, W. (2015) Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up. BMC Veterinary Research, 11: 228 http://dx.doi.org/10.1186/s12917-015-0548-9
Schwartz-Porsche, D. J. U. (1991) Wirksamkeit von Bromid bei den therapieresistenten Epilepsien des Hundes. Tierarztliche Praxis, 19 (4), pp. 395-401
Schwartz-Porsche, D., Loscher, W. and Frey, H. H. (1982) Treatment of canine epilepsy with primidone. Journal of the American Veterinary Medical Association, 181 (6), pp. 592-595
Schwartz-Porsche, D., Loscher, W. and Frey, H.H. (1985) Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacology and Therapeutics, 8 (2). pp. 113-119 http://dx.doi.org/10.1111/j.1365-2885.1985.tb00934.x
Scorza, F. A. et al. (2009) Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study. Epilepsy & Behavior, 15 (4), pp. 527-528 http://dx.doi.org/10.1016/j.yebeh.2009.05.013
Srivastava, M., Singh, N. K. and Srivastava, A. (2013) Management of Phenobarbital Refractory Idiopathic Epilepsy by Potassium Bromide in Dogs. Advances in Animal and Veterinary Sciences, 1 (1), pp. 25-27
Steinberg, M.F.D. (2004) Levetiracetam therapy for long-term idiopathic epileptic dogs. ACVIM Abstracts. Journal of Veterinary Internal Medicine, 18 (3), p. 410
Tipold, A. et al. (2015) Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs. Journal of Veterinary Pharmacology and Therapeutics 38 (2), pp. 160-168 http://dx.doi.org/10.1111/jvp.12151
Trepanier, L.A. et al (1998) Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association, 213 (10), pp. 1449-1453
Varshney, J. P. (2007) Clinical management of idiopathic epilepsy in dogs with homeopathic< i> Belladonna 200C: a case series. Homeopathy, 96 (1), pp. 46-48 http://dx.doi.org/10.1016/j.homp.2006.09.002
Volk, H.A. et al (2008) The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Veterinary Journal, 2008, 176 (3), pp.310-319 http://dx.doi.org/10.1016/j.tvjl.2007.03.002
Von Klopmann, T., Rambeck, B. and Tipold, A. (2007) Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of Small Animal Practice, 48 (3), pp. 134-138 http://dx.doi.org/10.1111/j.1748-5827.2006.00290.
License
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
Most read articles by the same author(s)
- Marios Charalambous, Sergio A. Gomes, Stella Papageorgiou, Massimo Orioles, Epileptic Seizures Versus Syncope: Pathophysiology and Clinical Approach , Veterinary Evidence: Vol. 2 No. 1 (2017): The first issue of 2017
- Marios Charalambous, David Brodbelt, Holger Andreas Volk, The Evidence Behind the Diagnostic Investigation of Canine Idiopathic Epilepsy , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
- Marios Charalambous, Surgery in Epilepsy – How Advances in Human Neurology Can Benefit Veterinary Patients , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
- Ellie Sellers, Sarah Baillie, Rachel Dean , Sheena Warman, Heidi Janicke, Sebastian P Arlt, Clare Boulton, Marnie Brennan, David Brodbelt, Fiona Brown, Louise Buckley, Myai Du, Emma Gallop, George Goran, Douglas JC Grindlay, Laura Haddock, Joanne Ireland, Catherine McGowan, Heather K Moberly, Emma Place, Md Mizanur Rahman, Gwen Rees, Kristen Reyher, Javier Sanchez, Johan P Schoeman, Laura Urdes, John VanLeeuwen, Kristien Verheyen, Promoting Evidence-based Veterinary Medicine through the online resource ‘EBVM Learning’: User feedback , Veterinary Evidence: Vol. 6 No. 1 (2021): The first issue of 2021
- Marios Charalambous, Antiepileptic Drugs’ Tolerability and Safety – a Systematic Review and Meta-analysis of Adverse Effects in Dogs , Veterinary Evidence: Vol. 1 No. 4 (2016): Our fourth issue
